Our CEO participates in the Korean pharma event

The conference took place on the 28th/29th October, and is organised by the Department for International Trade Healthcare and Life Sciences. Together with representatives from the Dundee Drug Discovery Unit and the Medicines Discovery Catapult, our CEO discussed the strengths of the life sciences sector in the U.K. and the opportunities that the sector offer […]

Read more
Glamorous AI announce a collaboration with Cardiff University on Covid-19 inhibitors

Glamorous AI forms a partnership with Cardiff University to discover possible Covid-19 drugs UK-based Artificial intelligence (AI) drug discovery company Glamorous AI has announced that it has entered into a research collaboration with Cardiff University focusing on the use of Glamorous AI’s platform for Covid-19 research. The partners will collaborate to discover novel inhibitors against […]

Read more
Rosalind’s computational docking available for Covid-19 researchers

Molecular docking can be an important step in analysing compound designs, filtering through huge chemical spaces and prioritising promising compounds. In our Covid-19 project (check it out here and read the paper here), docking and binding energy calculations are a big part of Rosalind’s prioritisation phase.  We know setting up a docking process for the scale necessary […]

Read more